Research to help the most vulnerable
Some people become only mildly ill when they ’catch’ viral or bacterial infections, whereas others are affected much more severely. But what are the reasons for these differences? And how can the course of a disease be predicted and personalised treatments developed?
These questions are being addressed by the RESIST Cluster of Excellence team. This will enable them to help people with a weakened immune system, including newborn babies, the elderly, people with congenital immunodeficiency, those whose immune system is suppressed for therapeutic reasons, and implant users.
Our research programme is for the weakest. The current threat of the corona pandemic clearly shows how important the goals of our Cluster of Excellence RESIST are. We want to better understand the variable susceptibility of individuals to infections in order to protect vulnerable people as well as possible. In view of the dramatic situation, we in RESIST are also researching around SARS-CoV-2.
RESIST – News
A step on the way to better therapies against viruses
Researchers show how a cell protein of the innate immune response prevents the multiplication of herpes viruses: Most body cells can defend themselves against viruses after they have been activated by the body's own messenger substances (interferons [...]
Nutrients instead of antibiotics
Can nutritional supplements prevent serious diseases in newborns? BMBF supports project of MHH, RESIST and UKW with 1.9 million euros: Blood poisoning (sepsis) is life-threatening - especially for premature babies, as they can die from it within a f [...]
A step on the way to better therapies against viruses
Researchers show how a cell protein of the innate immune response prevents the multiplication of herpes viruses: Most body cells can defend themselves against viruses after they have been activated by the body's own messenger substances (interferons [...]
Nutrients instead of antibiotics
Can nutritional supplements prevent serious diseases in newborns? BMBF supports project of MHH, RESIST and UKW with 1.9 million euros: Blood poisoning (sepsis) is life-threatening - especially for premature babies, as they can die from it within a f [...]
Cystic fibrosis and new therapeutic targets
From 21 June at 6 p.m., the lecture (in german language) by Professor Dr. Burkhard Tümmler, which he is giving as part of the Hannover Medical School's Patient University, can be viewed online. It revolves around the topic "Cystic fibrosis and new t [...]
